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AAA proteases comprise a conserved family of mem-
brane bound ATP-dependent proteases that ensures
the quality control of mitochondrial inner-membrane
proteins. Inactivation of AAA proteases causes pleio-
tropic phenotypes in various organisms, including res-
piratory deficiencies, mitochondrial morphology de-
fects, and axonal degeneration in hereditary spastic
paraplegia (HSP). The molecular basis of these defects,
however, remained unclear. Here, we describe a regula-
tory role of an AAA protease for mitochondrial protein
synthesis in yeast. The mitochondrial ribosomal protein
MrpL32 is processed by the m-AAA protease, allowing
its association with preassembled ribosomal particles
and completion of ribosome assembly in close proxim-
ity to the inner membrane. Maturation of MrpL32 and
mitochondrial protein synthesis are also impaired in a
HSP mouse model lacking the m-AAA protease sub-
unit paraplegin, demonstrating functional conserva-
tion. Our findings therefore rationalize mitochondrial
defects associated with m-AAA protease mutants in
yeast and shed new light on the mechanism of axonal
degeneration in HSP.
Introduction
Energy-dependent proteases perform essential roles in
cellular regulation and homeostasis. They degrade mis-
folded polypeptides and prevent their accumulation
and potential deleterious effects on cellular activities.
At the same time, they control the stability of regulatory
proteins and thereby central cellular processes. This
dual activity is exemplified by the ubiquitin-proteasome
system in the eukaryotic cytosol, which mediates the
majority of proteolysis occurring in the cytosol and nu-
cleus of eukaryotic cells (Ciechanover, 2005). Protea-
somes degrade substrate proteins processively but, in
some cases, also activate transcription factors by spe-
cifically processing inactive precursor forms (Rape and
Jentsch, 2004). In addition to proteasomes, eukaryotic
cells harbor energy-dependent proteases only in mito-*Correspondence: thomas.langer@uni-koeln.de
3 Present address: Division of Biochemistry and Genetics, Istituto
Nazionale Neurologico C. Besta, 20126 Milan, Italy.chondria and chloroplasts. These endosymbiotic or-
ganelles contain conserved proteolytic systems with
ATP-dependent proteases highly homologous to bacte-
rial Lon-, Clp-, or FtsH-like AAA proteases (Van Dyck
and Langer, 1999).
The function of these ubiquitously distributed prote-
ases is currently best understood in Saccharomyces
cerevisiae, where pleiotropic phenotypes have been
observed in cells carrying inactive variants of these en-
zymes. Cells lacking the matrix-localized Lon/PIM1
protease accumulate mutations in mitochondrial DNA
and loose respiratory competence since essential res-
piratory-chain subunits are encoded within mitochondria
(Suzuki et al., 1994; Van Dyck et al., 1994). Similarly,
respiration is impaired in yeast cells lacking an AAA
protease. Two AAA proteases are present in the inner
membrane of mitochondria (Nolden et al., 2005). These
membrane bound proteolytic complexes are built up of
homologous subunits with ATP-dependent metallopep-
tidase activity but are exposed to opposite membrane
surfaces. The i-AAA protease is composed of Yme1
subunits and is active on the intermembrane side
(Leonhard et al., 1996). Deletion of YME1 leads to respi-
ratory deficiencies (Thorsness et al., 1993) and the ac-
cumulation of mitochondria with an aberrant morphol-
ogy (Campbell et al., 1994). Subunits of the m-AAA
protease expose their catalytic sites to the matrix.
m-AAA proteases constitute hetero-oligomeric com-
plexes that are composed of Yta10 (Afg3) and Yta12
(Rca1) subunits in yeast (Arlt et al., 1996) and Afg3l2
and paraplegin subunits in human mitochondria (Ator-
ino et al., 2003). In the absence of the m-AAA protease,
yeast cells are respiratory deficient and lack assembled
respiratory-chain and F1FO-ATP synthase complexes
(Arlt et al., 1998; Galluhn and Langer, 2004). In humans,
loss-of-function mutations of paraplegin cause heredi-
tary spastic paraplegia (HSP) (Casari et al., 1998), a
neurodegenerative disorder characterized by axonal
degeneration of motor neurons of the corticospinal
tracts and sensory neurons of the fasciculus gracilis
(McDermott et al., 2000). These phenotypes were also
observed in a paraplegin-deficient mouse model that
revealed the accumulation of aberrant mitochondria in
the distal regions of affected axons at early stages of
the disease (Ferreirinha et al., 2004).
None of these phenotypes, neither in yeast nor in
mammals, is currently understood on the molecular
level. AAA proteases are main players of the quality-
control system in the inner membrane of mitochondria
and have been demonstrated to degrade a large num-
ber of nonnative membrane proteins. Mitochondrial
activities may therefore be impaired by the accumula-
tion of misfolded polypeptides upon inactivation of
AAA proteases. As protein aggregates have not been
detected in these mitochondria, it is also conceivable
that specific mitochondrial proteins with regulatory
functions exist whose impaired proteolysis interferes
with mitochondrial activities. Such substrate proteins,
however, have not been identified.
Here, we describe the characterization of MrpL32, a
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278Figure 1. Processing of MrpL32 by the m-AAA Protease in Yeast Mitochondria
(A) Copurification of MrpL32 and prohibitins with the m-AAA protease. Mitochondria isolated from yta10yta12 mitochondria expressing
either Yta10E559Q-his and Yta12E614Q (yta10EQ/HISyta12EQ) or, for control, untagged Yta10E559Q and Yta12E614Q (yta10EQyta12EQ) were fraction-
ated by metal chelating chromatography. Eluate fractions were analyzed by SDS-PAGE and stained with colloidal Coomassie.
(B) m-AAA protease-dependent processing of MrpL32 upon import into mitochondria. MrpL32 was synthesized in a cell-free system in the
presence of [35S]methionine and imported posttranslationally for 30 min at 25°C into wild-type (wt), yta10, and yta12 mitochondria. The
membrane potential across the inner membrane was dissipated by adding valinomycin prior to (−Ψ) or after completion of import (+Ψ).
Nonimported preproteins were degraded by Proteinase K (PK, 50 g/ml). To examine the submitochondrial localization of newly imported
MrpL32, the outer membrane was disrupted by osmotic swelling (+SW) followed by incubation of the samples with PK (50 g/ml) for 30 min
at 4°C. The samples were analyzed by SDS-PAGE and autoradiography. The integrity of mitochondria was monitored by immunoblotting
against the soluble intermembrane-space protein cytochrome b2 (Cytb2) and the matrix protein Mge1. p, precursor MrpL32; m, mature
MrpL32.
(C) Alignment of homologous MrpL32 sequences from yeast (uniprot:rm32_yeast), human (uniprot:rm32_human), mouse (uniprot:rm32_
mouse), and E. coli (uniprot:rl32_ecoli). The alignment was constructed by ClustalW. The colors indicate the degree of similarity: blue, all
amino acids of a column are identical, red, half of the amino acids of a column are identical or belong to a group with strong similarity, yellow,
more than half of the amino acids of a column belong to a group with weak similarity. The processing site in yeast MrpL32 is indicated by
an arrow.
(D) N-terminal processing of MrpL32 in vivo. Processing of MrpL32 was monitored in isolated mitochondria using polyclonal antisera directed
against the mature or the precursor form of MrpL32. Analyzed yeast strains include wt, mrpl32, yta10, yta12, yta10EQ (yta10 expressing
Yta10E559Q), yta12EQ (yta12 expressing Yta12E614Q) and yta10EQyta12EQ.
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279subunit of mitochondrial ribosomes, as a proteolytic
substrate of m-AAA proteases and assign a crucial
function for the control of mitochondrial protein synthe-
sis to this protease in both yeast and mouse.
Results
Identification of MrpL32 as Substrate
of the m-AAA Protease
In order to identify substrate proteins of the m-AAA pro-
tease in mitochondria, Yta10E559Q and Yta12E614Q, both
harboring point mutations in the proteolytic center,
were expressed in yta10yta12 yeast cells. The m-AAA
protease complex, which is formed upon assembly of
both mutant proteins, is still capable of substrate bind-
ing but lacks proteolytic activity (Arlt et al., 1998) and,
therefore, can be used as a trap to identify short-lived
substrate proteins. Moreover, we fused a hexahistidine
peptide to the C terminus of Yta10, allowing purification
of the protease by metal chelating chromatography.
Mitochondrial extracts of yta10yta12 yeast cells har-
boring Yta12E614Q and tagged or untagged Yta10E559Q
were fractionated by NiNTA-chromatography (Figure
1A). Yta12 coeluted with Yta10, demonstrating assem-
bly of both subunits of the m-AAA protease. Further-
more, Phb1 and Phb2 were detected in the eluate (Fig-
ure 1A). Both proteins constitute the prohibitin complex
in the inner membrane that associates with the m-AAA
protease and modulates its activity (Steglich et al., 1999).
In addition to these known interactors, an additional
protein, identified by peptide mass fingerprint analysis
as MrpL32, a component of the large mitochondrial ri-
bosomal subunit (Grohmann et al., 1991), specifically
copurified with the m-AAA protease.
MrpL32 Is Processed by the m-AAA Protease
The copurification of MrpL32 with proteolytically inactive
m-AAA protease suggests that it represents a novel
proteolytic substrate. We therefore synthesized MrpL32
in a cell-free system in the presence of [35S]methionine
and incubated the radiolabeled protein with mito-
chondria isolated from wild-type, yta10, and yta12
cells (Figure 1B). MrpL32 was imported in a membrane-
potential-dependent manner and was protease pro-
tected in wild-type mitochondria. A smaller form of
MrpL32 was generated upon import, indicating proteo-
lytic processing. Strikingly, maturation of MrpL32 did
not occur in mitochondria lacking the m-AAA protease
(Figure 1B). The processing defect was not caused by
an impaired import of MrpL32, which was localized in
the matrix in both wild-type and mutant mitochondria
(Figure 1B). These findings indicate that the m-AAA
protease mediates the processing of newly imported
MrpL32.
MrpL32 is a conserved component of the large ribo-
somal particle, with homologs present in eubacteria
and mitochondria of eukaryotic cells (Figure 1C). Se-
quencing of MrpL32 after purification of mitochondrial
ribosomes identified alanine 72 as the N-terminal amino
acid of MrpL32 (Grohmann et al., 1991). This residue is
present within a highly conserved sequence motif and
represents the N-terminal residue in bacterial MrpL32proteins, whereas eukaryotic homologs carry an amino-
terminal extension (Figure 1C).
To monitor m-AAA protease-dependent maturation of
MrpL32 in vivo, we raised polyclonal antisera that were
directed against amino acid residues located before and
after the predicted cleavage site. Unexpectedly, the pre-
cursor form of MrpL32 was only detected by antibodies
recognizing the presequence peptide of MrpL32 but not
by those directed against mature MrpL32. We used these
antibodies to detect MrpL32 in mitochondria lacking
the m-AAA protease or harboring proteolytically in-
active variants of Yta10, Yta12, or both (Figure 1D). In
agreement with our import experiments, the precursor
form of MrpL32 was found in mitochondria lacking
m-AAA protease. Mature MrpL32, on the other hand, was
generated both in wild-type and in either Yta10E559Q or
Yta12E614Q mitochondria (Figure 1D). In contrast to
yta10E559Qyta12E614Q cells, these mitochondria still har-
bor a proteolytically active m-AAA protease subunit
that assembles with the mutant protein and thereby is
capable of maintaining respiratory growth (Arlt et al.,
1998). We therefore conclude from these experiments
that maturation of MrpL32 in vivo depends on proteoly-
sis by the m-AAA protease.
The Presequence of MrpL32 Is Essential but Not
Sufficient for Mitochondrial Targeting
Although the 71 N-terminal amino acid residues of
MrpL32 do not have the propensity to form positively
charged, amphiphilic α helices, a characteristic feature
of mitochondrial targeting sequences, their deletion
completely abolished import of MrpL32 into isolated
mitochondria (Figure 2A). Thus, amino acid residues
1–71 are essential for mitochondrial targeting of
MrpL32. To assess whether they are also sufficient to
drive import of a heterologous reporter protein, we
fused MrpL32 or amino-terminal segments of MrpL32
of various lengths to murine dihydrofolate reductase
(DHFR) and examined the import competence of the
resulting hybrid proteins (Figure 2B). In contrast to
MrpL32 (1–183)-DHFR containing complete MrpL32, a
hybrid protein composed of the presequence of
MrpL32 and DHFR (MrpL32 (1–71)-DHFR) was not im-
ported into mitochondria, demonstrating that the prese-
quence of MrpL32 is not sufficient to ensure mitochon-
drial targeting (Figure 2B). We observed, however,
efficient import if at least 77 amino-terminal amino acid
residues of MrpL32 were fused to DHFR, assigning a
crucial function to amino acid residues 72–77 of
MrpL32 (Figure 2B). These results suggest that essen-
tial targeting information is contained in both the prese-
quence and the 6 N-terminal amino acids of mature
MrpL32. Notably, a cluster of three positively charged
amino acid residues that are likely to be crucial for
mitochondrial targeting is present in the latter segment
(Figure 1C).
Rescue of Respiratory Growth of m-AAA Protease-
Deficient Cells by Mature MrpL32
Cells lacking MrpL32 are respiratory incompetent (Fig-
ure 2C). To examine whether maturation of MrpL32 is
sufficient to ensure its functionality within mitochondria,
we replaced the presequence of MrpL32 by amino acid
Cell
280Figure 2. MrpL32 Processing Is Crucial for Respiratory Growth of m-AAA Protease-Deficient Yeast Cells
(A and B) The N-terminal region of MrpL32 is required for mitochondrial targeting. 35S-labeled (A) MrpL32 (1–183) and MrpL32 (72–183) or (B)
MrpL32 (1–71)-DHFR, MrpL32 (1–77)-DHFR, MrpL32 (1–90)-DHFR, and MrpL32 (1–183)-DHFR were imported into wt and yta10 mitochondria
as described in Figure 1B. Samples were analyzed by SDS-PAGE and autoradiography.
(C) Respiratory growth of mrpl32 cells is maintained by mature MrpL32 targeted to mitochondria by a heterologous presequence. MrpL32
and Su9 (1–69)-MrpL32 (72–183) were expressed in a diploid MRPL32/mrpl32 strain. Haploid meiotic progenies lacking genomic MRPL32
but expressing MrpL32 or Su9 (1–69)-MrpL32 (72–183) were isolated by sporulation and tetrad dissection. Cell growth was examined on
glucose (YPD) or glycerol (YPG) containing media. In contrast to MrpL32, Su9 (1–69)-MrpL32 (72–183) only restored respiratory growth of
mrpl32 cells when expressed from a multicopy plasmid.
(D) Steady-state level of MrpL32 in mitochondria isolated from wt, yta10, and mrpl32 cells and mrpl32, yta10mrpl32, and yta10 cells
expressing Su9 (1–69)-MrpL32 (72–183) (“Su9-MrpL32”). The precursor-form (p) and mature MrpL32 (m) were detected immunologically. A
crossreacting band is marked with an asterisk.
(E) Expression of Su9 (1–69)-MrpL32 (72–183) partially restores respiratory competence of m-AAA protease-deficient cells. Su9 (1–69)-MrpL32
(72–183) was expressed in yta10 and yta10mrpl32 cells, and respiratory growth on nonfermentable carbon sources (YPG) was examined
after 7 days.residues 1–69 of subunit 9 of the F1FO-ATPase of Neu-
rospora crassa. This amino acid region serves as a
mitochondrial targeting sequence and includes cleav-




MMPP) after amino acids 35 and 66 (Ungermann et al.,
994). Haploid mrpl32 cells expressing the hybrid pro-
ein Su9 (1–69)-MrpL32 (72–183) and, for control,
rpL32 were obtained from diploid MRPL32/mrpl32
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tory competence of mrpl32 cells and allowed growth
on glycerol-containing media (Figure 2C). Although ov-
erexpressed, mature MrpL32 accumulated at slightly
reduced levels in mitochondria isolated from these cells
(Figure 2D). Maturation of Su9 (1–69)-MrpL32 (72–183)
occurred irrespective of the presence of the m-AAA
protease within mitochondria and was mediated by
MPP (see Figure S1 in the Supplemental Data available
with this article online): processing was impaired in
mitochondria harboring a temperature-sensitive variant
of the α subunit of MPP (mas2; Jensen and Yaffe, 1988),
while it effectively occurred in vitro by adding purified
MPP. We conclude from these experiments that pro-
cessing of MrpL32 is required and sufficient for its func-
tion within mitochondria and, concomitantly, for respi-
ratory growth.
As respiratory growth depends on MrpL32 process-
ing, an impaired maturation of MrpL32 could underlie
the respiratory deficiency of cells lacking the m-AAA
protease. To examine this possibility, we expressed Su9
(1–69)-MrpL32 (72–183) in yta10 and yta10mrpl32
cells and assessed growth on glycerol-containing me-
dium. Strikingly, the presence of mature MrpL32 par-
tially suppressed the respiratory-growth phenotype of
yta10 and yta10mrpl32 cells (Figure 2E), identifying
the maturation of MrpL32 as a key function of the
m-AAA protease within mitochondria. It remains to be
determined whether the slow growth of yta10 cells
harboring mature MrpL32 is caused by the reduced
steady-state concentration of MrpL32 in mitochondria
or by the impaired proteolysis of additional substrate
proteins of the m-AAA protease.
The m-AAA Protease Controls
Mitochondrial Translation
In further experiments, we examined protein synthesis
in m-AAA protease-deficient mitochondria and labeled
mitochondrial-translation products in the presence of
[35S]methionine and cycloheximide in wild-type cells,
yta10 as well as yta12 cells, and, for control, mrpl32
and yme1 cells lacking the i-AAA protease (Figure 3A).
The synthesis of mitochondrially encoded proteins was
strongly impaired in cells lacking the m-AAA protease,
indicating that mitochondrial translation depends on
maturation of MrpL32. Protein synthesis within mito-
chondria is required to maintain the integrity of mtDNA
(Myers et al., 1985), and, indeed, mrpl32 mitochondria
accumulate deletions in the mtDNA (ρ−; data not shown).
Impaired translation in yta10 and yta12 cells could
therefore explain early observations of an increased
rate of mtDNA loss in these cells (Guélin et al., 1994).
Ribosomal Particles Are Assembled but Fail
to Integrate MrpL32 in Mitochondria
Lacking m-AAA Protease
How does an impaired processing of MrpL32 affect the
synthesis of mitochondrially encoded proteins? As a sub-
unit of the large ribosomal particle, MrpL32 may be
required for ribosome assembly within mitochondria.
Therefore, steady-state levels of various ribosomal sub-
units were determined in mitochondria lacking proteolyti-
cally active m-AAA protease and compared to wild-typemitochondria. However, we did not detect differences in
the levels of components of the large ribosomal particle
such as Mrp7, Mrp20, and Mrp49 or in levels of the small
ribosomal particle subunit Mrp13 (Figure 3B).
These findings indicate that, in the absence of the
m-AAA protease, ribosome assembly either occurs nor-
mally or is impaired at a late stage, at which ribosomal
subunits are protected against proteolytic degradation.
To distinguish between these possibilities, ribosome
assembly was directly assessed in mitochondrial ex-
tracts of wild-type, yta10, yta12, and mrpl32 mito-
chondria by sucrose-gradient centrifugation (Figures
3C and 3D). Assembled 54S and 70S ribosomal par-
ticles were detected by exploiting the absorption of ri-
bosomal RNA at 254 nm or by immunoblot analysis of
gradient fractions. Similar absorption and elution pro-
files were observed when wild-type, yta10, or yta12
mitochondria were analyzed (Figure 3C). Moreover,
fractionation of 37S particles, monitored by the small
ribosomal protein Mrp13, was unaffected in yta10 and
yta12 mitochondria (Figure 3D). This is in contrast
to mrpl32 mitochondria, which lack intact mtDNA and
do not accumulate assembled ribosomes (Figures 3C
and 3D).
While these experiments demonstrate that ribosomal
particles are largely assembled in the absence of the
m-AAA protease, they revealed an impaired recruitment
of MrpL32 into the large subunit (Figure 3D). The pre-
cursor form of MrpL32 did not cofractionate with 54S
and 70S particles and was recovered in top fractions of
the gradient. We conclude that maturation of MrpL32
by the m-AAA protease is dispensable for the formation
of preassembled 54S and 70S ribosomal particles but
essential for the integration of MrpL32 itself into this
complex. This step therefore must occur at late stages
of the assembly process.
Mature MrpL32 Is Associated
with the Inner Membrane
Mitochondrial ribosomes have been found in associa-
tion with the inner membrane, to which they are bound
in a salt-sensitive manner (Spithill et al., 1978; Van der
Klei et al., 1994; Liu and Spremulli, 2000). We assessed
a potential membrane association of MrpL32 by soni-
cation of mitochondria (Figures 4A and 4B). Whereas
other subunits of the large ribosomal particle were
membrane bound but released in a salt-dependent
manner, mature MrpL32 remained in the membrane pel-
let even at high salt concentrations (Figure 4A). An in-
teraction of mature MrpL32 with the inner membrane
was also suggested after extraction of mitochondrial
membranes with Triton X-114 (Figure 4C). Whereas
other ribosomal proteins, including the precursor form
of MrpL32 accumulating in yta10 mitochondria (Figure
4B), were detected in the supernatant fraction, mature
MrpL32 was exclusively recovered in the membrane
pellet (Figure 4C). Thus, although lacking potential
membrane-spanning domains, mature MrpL32 appears
to be tightly associated with the inner membrane. It
should be noted that membrane binding of MrpL32 is
not essential for tethering of ribosomes to the mem-
brane surface. Other ribosomal subunits were found in
association with the inner membrane of yta10 mito-
chondria lacking mature MrpL32 (Figure 4B).
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282Figure 3. Impaired Translation and MrpL32 Assembly in m-AAA Protease-Deficient Mitochondria
(A) Labeling of mitochondrial-translation products in vivo. wt, yta10, yta12, mrpl32, and yme1 cells were grown at 30°C and labeled for
10 min with [35S]methionine in the presence of cycloheximide. The synthesis of mitochondrially encoded proteins was monitored by SDS-
PAGE and autoradiography (upper panel) and quantified by determining total incorporated radioactivity (lower panel).
(B) Steady-state levels of ribosomal proteins in mitochondria lacking m-AAA protease activity. Mitochondria isolated from the yeast strains
indicated were analyzed by immunoblotting using polyclonal antibodies directed against subunits of the large ribosomal particle (Mrp7,
Mrp20, and Mrp49) and against Mrp13, a subunit of the small ribosomal particle.
(C and D) Accumulation of ribosomal particles in mitochondria lacking m-AAA protease. Ribosome assembly was assessed by sucrose-
gradient centrifugation in mitochondria isolated from wt, yta10, yta12, and mrpl32 cells. 37S, 54S, and 70S particles were detected (C)
by measuring the absorption of ribosomal RNA at 254 nm and (D) by immunoblot analysis of gradient fractions using polyclonal antisera
directed against mature MrpL32 (MrpL32), the precursor form of Mrpl32 (MrpL32N), Mrp49, Mrp20, and Mrp13.
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(A–C) Membrane association of MrpL32 in wild-type and m-AAA protease-deficient mitochondria. Mitochondria isolated from (A) wt or (B)
yta10 cells were lysed by sonication in the presence of increasing concentrations of KCl. Membrane-associated and soluble proteins were
separated by centrifugation, and mature MrpL32 (m, %), the precursor form of MrpL32 (p, $), Mrp49 (:), and Mrp13 (6) were detected
immunologically in both fractions. The membrane-associated fraction of each protein is given as percentage of the total. (C) Mitochondrial
membranes were extracted with Triton X-114, and the total sample was divided into a pellet (P) and supernatant (S) fraction by centrifugation.
The pellet fraction contains membrane proteins, whereas soluble proteins are recovered in the supernatant. Fractions were analyzed by
immunoblot analysis using antisera directed against mature MrpL32 (m), the precursor form of MrpL32 (p), Mrp20, the ADP/ATP carrier (Aac2),
and cytochrome b2 (Cytb2).
(D and E) A large MrpL32-containing complex. Superose 6 sizing chromatography (D) and sucrose-gradient centrifugation (E) of mitochondrial
digitonin extracts. Mature MrpL32 and the m-AAA protease subunit Yta10 were detected by immunoblot analysis. The m-AAA protease
(w1 MDa) and the m-AAA protease-prohibitin complex (w2 MDa) in the eluate of the sizing chromatography (D) are indicated.The different behavior of mature and precursor forms
of MrpL32 in these experiments suggests that process-
ing by the m-AAA protease triggers a conformational
transition which allows the assembly of mature MrpL32
to proceed in close proximity to the inner membrane.
In contrast to the precursor form of MrpL32, matureMrpL32 was indeed recovered in a high-molecular-
mass complex upon fractionation of mitochondrial ex-
tracts by sucrose-gradient centrifugation (Figure 3D) or
sizing chromatography (Figure 4D). Notably, only a
small portion of mature MrpL32 comigrated with as-
sembled large ribosomal subunits in these experi-
Cell
284ments. MrpL32 is either bound to ribosomes with low
affinity, leading to its dissociation upon fractionation, or
is part of yet another complex prior to integration in
assembled ribosomes. The native molecular mass of
the MrpL32-containing complex was estimated to be
larger than 1 MDa (Figure 4D). It partially cofractionated
with the m-AAA protease upon sucrose-gradient cen-
trifugation or sizing chromatography of mitochondrial
extracts, but coimmunoprecipitation experiments did
not provide any evidence for binding of mature MrpL32
to the protease (Figures 4D and 4E; data not shown). A
potential binding partner of mature MrpL32 thus re-
mains to be identified; however, our experiments sug-
gest that maturation of MrpL32 is not strictly coupled to
its assembly with 54S particles, which occurs in close
proximity to the inner membrane.
Processing of MrpL32 by the Murine m-AAA
Protease Composed of Afg3l2 and Paraplegin
As both MrpL32 and the m-AAA protease are con-
served throughout evolution, it is conceivable that mat-
uration of MrpL32 is mediated by the m-AAA protease
also in higher eukaryotes. Recent complementation
studies identified a hetero-oligomeric complex built up
of human AFG3L2 and paraplegin as the ortholog of the
yeast m-AAA protease (Atorino et al., 2003). Similarly,
respiratory competence of yta10yta12 cells was re-
stored upon coexpression of both murine Afg3l2 and
paraplegin, defining the Afg3l2/paraplegin complex as
the murine ortholog of the yeast m-AAA protease (Fig-
ure 5A). The respiratory growth of yta10yta12 cells
harboring murine Afg3l2 and paraplegin suggests that
processing of yeast MrpL32 (yMrpL32) was restored in
these cells. Indeed, maturation of yMrpL32 was de-
tected in mitochondria isolated from these cells upon
immunoblotting, demonstrating maturation of yMrpL32
by the murine m-AAA protease (Figure 5B).
Murine MrpL32 (mMrpL32) was synthesized in a cell-
free system in the presence of [35S]methionine and in-
cubated with isolated yeast mitochondria to examine
m-AAA protease-dependent processing (Figure 5C;
Figure S2). Similar to yMrpL32, mMrpL32 was imported
into yeast mitochondria in a membrane-potential-depen-
dent manner and processed to the mature form. Pro-
cessing was inhibited in mitochondria lacking Yta10
and Yta12, demonstrating that maturation of mMrpL32
occurred by the yeast m-AAA protease (Figure 5C; Fig-
ure S2). Mature mMrpL32 was also detected upon
import of mMrpL32 into yta10yta12 mitochondria
containing Afg3l2 and paraplegin, providing direct evi-
dence that mMrpL32 can be processed by the murine
m-AAA protease (Figure 5C; Figure S2).
Impaired mMrpL32 Processing and Protein
Synthesis in Paraplegin-Deficient
Murine Mitochondria
To investigate the relevance of proteolytic processing
of mMrpL32 in vivo, we raised a polyclonal antiserum
against mMrpL32 and analyzed processing of MrpL32
in murine liver mitochondria from wild-type and para-
plegin−/− mice (Figure 6A) (Ferreirinha et al., 2004). Ma-
ture mMrpL32 was detected in wild-type mitochondria,



















Sigure 5. m-AAA Protease-Dependent Processing of MrpL32 Is
onserved from Yeast to Mammals
A) Maintenance of respiratory growth of yta10yta12 cells
pon coexpression of murine Afg3l2 and paraplegin. wt cells;
yta10yta12 cells; and yta10yta12 cells expressing Afg3l2 and
araplegin, both fused to the mitochondrial targeting sequence of
ta10, were grown on fermentable (YPD) or nonfermentable (YPG)
arbon sources at 30°C.
B) Maturation of yeast MrpL32 by the murine m-AAA protease.
rocessing of yeast MrpL32 was monitored immunologically in wt
nd yta10yta12 mitochondria and in yta10yta12 mitochondria
arboring Afg3l2 and paraplegin as in Figure 1D.
C) Processing of newly imported murine MrpL32 in yeast mito-
hondria by yeast and murine m-AAA proteases. 35S-labeled mu-
ine MrpL32 was imported into wt and yta10yta12 mitochondria
nd into yta10yta12 mitochondria containing Afg3l2 and para-
legin as in Figure 1B, and processing was assessed. Mature mu-
ine MrpL32 imported into wild-type mitochondria was set to 100%.
ee also Figure S2.
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tion in Murine Mitochondria Lacking Paraplegin
Liver mitochondria were isolated from 11-month-old wt and homo-
zygous paraplegin−/− mice (−/−).
(A) Steady-state level of MrpL32 in mitochondria lacking para-
plegin. The accumulation of MrpL32 was assessed immunologi-
cally using a polyclonal antisera directed against murine MrpL32.
The precursor form accumulated to a variable extent in different
mitochondrial preparations. p, precursor form of MrpL32; m, ma-
ture form of MrpL32.
(B and C) Mitochondrial protein synthesis in the absence of para-
plegin. Mitochondrially encoded proteins were synthesized in wtm-AAA protease within mitochondria is directly indi-
and paraplegin-deficient mitochondria in the presence of [35S]
methionine at 30°C for the time points indicated. (B) Newly synthe-
sized proteins were analyzed by SDS-PAGE and autoradiography.
(C) The efficiency of translation in seven independent experiments
was quantified (±SEM), and the statistical significance was as-
sessed by a paired Student’s t test (p < 0.05).
(D) Quantification of mtDNA by Southern blot analysis. Total DNA
was isolated from liver of four 12-month-old wt and paraplegin−/−
mice and digested with BglII to linearize the mtDNA. Southern
analysis was performed using probes corresponding to either to
the D loop or the ND-1 gene.mitochondria lacking paraplegin. In addition, a larger
band accumulated in these mitochondria that comi-
grated with the precursor form of MrpL32, indicating
an impaired maturation of MrpL32 (Figure 6A). We then
determined the kinetics and the efficiency of protein
synthesis in isolated paraplegin-deficient liver mito-
chondria and labeled mitochondrially encoded proteins
with [35S]methionine (Figure 6B). Mitochondrial transla-
tion was significantly impaired in the absence of para-
plegin and dropped byw50% when compared to wild-
type mitochondria (Figures 6B and 6C). Southern blot
experiments revealed that reduced translation in para-
plegin-deficient mitochondria is not caused by a loss
of mtDNA (Figure 6D). We conclude from these experi-
ments that maturation of mMrpL32 and mitochondrial
protein synthesis are impaired in paraplegin-deficient
mice.
Discussion
The biogenesis of the respiratory chain and the F1FO-
ATP synthase in the inner membrane depends on the
assembly of nuclear and mitochondrially encoded sub-
units and thus on the coordinated expression of both
cellular genomes. We demonstrate that protein synthe-
sis within mitochondria is under the proteolytic control
of the ATP-dependent m-AAA protease in both yeast
and mouse (Figure 7): newly imported MrpL32, a sub-
unit of the large ribosomal particle, is processed by the
m-AAA protease, resulting in its tight association with
the inner membrane. We propose that the membrane
recruitment of preassembled 54S particles allows bind-
ing of mature MrpL32 and completion of ribosome as-
sembly. Thus, the m-AAA protease not only ensures the
quality control of inner-membrane proteins but also ex-
erts a regulatory function during mitochondrial bio-
genesis.
Inhibition of MrpL32 maturation is sufficient to ex-
plain all phenotypes observed in m-AAA protease-defi-
cient yeast cells. As subunits of respiratory-chain com-
plexes and of the F1FO-ATP synthase are encoded in
the mitochondrial genome, mitochondrial-translation
defects impair the assembly of these protein com-
plexes in the inner membrane. Moreover, we previously
observed deficiencies in the splicing of intron-contain-
ing transcripts in yeast mitochondria lacking the
m-AAA protease (Arlt et al., 1998). Splicing of these in-
trons depends on intron-encoded RNA maturases and
thereby on mitochondrial translation. That processing
of MrpL32 represents indeed a central function of the
Cell
286Figure 7. Proteolytic Control of Mitochondrial Protein Synthesis
See text for details. X, putative assembly partner of mature MrpL32; OXA, Oxa1 export machinery; TOM, translocase of outer membrane;
TIM, translocase of inner membrane; OM, outer membrane; IMS, intermembrane space; IM, inner membrane; M, matrix.cated by our complementation experiments. The respi-
ratory growth of yta10 cells can be maintained if
mature MrpL32 is targeted to mitochondria by a heter-
ologous presequence cleaved off upon import by MPP.
We therefore conclude that an impaired proteolytic
control of crucial regulatory processes, rather than del-
eterious effects of misfolded polypeptides, causes
mitochondrial dysfunction in cells lacking the m-AAA
protease.
The dual role of the m-AAA protease in protein quality
control and ribosome assembly in mitochondria also
raises the intriguing possibility that mitochondrial
translation is regulated by a negative-feedback loop.
Accumulating nonnative substrates of the m-AAA pro-
tease may compete with MrpL32 for binding to the
m-AAA protease and thereby impair MrpL32 process-
ing and mitochondrial protein synthesis. Substrates
could include excess respiratory subunits in case of an
unbalanced nuclear and mitochondrial gene expression
but also oxidatively damaged proteins in aged cells.
MrpL32 becomes tightly associated with the inner
mitochondrial membrane upon processing by the
m-AAA protease and is recruited to ribosomes only at
a late stage of their assembly. The crystal structure of
the large ribosomal subunits of the eubacterium Deino-
coccus radiodurans (Harms et al., 2001) revealed that
MrpL32 is largely surface exposed (Figure S3). Notably,
an N-terminal segment protrudes deeply into the inte-
rior of the particle, rationalizing the need of proteolytic
processing for MrpL32 assembly (Figure S3). These
findings suggest that ribosome assembly is completed
at the inner membrane and that only membrane bound
ribosomes are translationally active. Previous observa-
tions indeed demonstrate that mitochondrial protein
synthesis occurs in close proximity to the inner mem-
brane (Spithill et al., 1978; Van der Klei et al., 1994; Liu
and Spremulli, 2000). The majority of the mitochon-
drially encoded proteins in yeast and mouse are sub-





































mo insert cotranslationally into the inner membrane.
heir expression depends on several mRNA-specific
ranslational activators, all of them tightly bound to the
nner membrane of mitochondria (Michaelis et al., 1991;
cMullin and Fox, 1993; Naithani et al., 2003; Krause-
uchholz et al., 2004). Moreover, the only soluble pro-
ein encoded in the mitochondrial genome of yeast, the
mall ribosomal subunit Var1, was recently demon-
trated to be synthesized at membrane-associated ri-
osomes (Fiori et al., 2003).
How the interaction of ribosomes with the inner
embrane is maintained is only partially understood.
xa1, mediating the membrane insertion of the mito-
hondrial and nuclear encoded proteins from the matrix
ide, has been demonstrated to bind to MrpL23, which
s located at the polypeptide exit channel of the large
ibosomal particle (Jia et al., 2003; Szyrach et al., 2003)
see also Figure S3). However, as ribosomes remain as-
ociated with Oxa1-deficient inner membranes (unpub-
ished data), additional binding sites appear to exist.
otably, OXA1 has been identified as a multicopy sup-
ressor of the respiratory deficiency of yeast cells lack-
ng the m-AAA protease (Rep et al., 1996). In view of
ur findings, this observation can be explained by an
ncreased recruitment of mitochondrial ribosomes to
he inner membrane or, more likely, to specialized re-
ions within the membrane. An increased local concen-
ration of preassembled 54S particles may then allow
he binding of very low amounts of mature MrpL32 pre-
ent in m-AAA protease-deficient mitochondria and,
oncomitantly, respiratory growth.
Processing of MrpL32 by the m-AAA protease is con-
erved throughout evolution. On one hand, murine
rpL32 is cleaved by the yeast m-AAA protease upon
mport into yeast mitochondria. On the other hand,
aturation of the yeast MrpL32 is at least partially re-
tored upon expression of the murine m-AAA protease
omposed of Afg3l2 and paraplegin. The processing of
urine MrpL32 imported into yeast mitochondria har-
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287boring Afg3l2 and paraplegin provides direct evidence
for a m-AAA protease-dependent maturation of MrpL32
also in mice. Consistently, we observed MrpL32 pro-
cessing deficiencies and an impaired mitochondrial
translation in paraplegin-deficient murine liver mito-
chondria.
It is therefore conceivable that an impaired mitochon-
drial protein synthesis is linked to axonal degeneration
in HSP caused by the loss of paraplegin. Mitochondrial
defects have been observed both in fibroblasts derived
from human patients and in paraplegin-deficient mice
(Atorino et al., 2003; Ferreirinha et al., 2004). The pro-
gressive nature of HSP could be explained by the age-
dependent accumulation of oxidatively damaged sub-
strates of the m-AAA protease, causing an impairment
of MrpL32 processing with age. It should be empha-
sized, however, that HSP is characterized by an intrigu-
ing tissue specificity, with neurons of the corticospinal
tract and the fasciculus gracilis being selectively af-
fected (McDermott et al., 2000). On a first glance, this
is difficult to reconcile with a defective mitochondrial
translation, a housekeeping function within mito-
chondria. However, a heterogeneous spectrum of clin-
ical phenotypes with mitochondrial deficiencies in vari-
ous tissues has been observed in patients who carry
mutations in mitochondrial DNA affecting mitochondrial
protein synthesis (DiMauro and Schon, 2003; Jacobs
and Turnbull, 2005; Taylor and Turnbull, 2005). Tissue-
specific phenotypes can be rationalized by different
sensitivities of various cells for mitochondrial dysfunc-
tion (Rossignol et al., 2003). Tissues like brain, muscle,
and heart with a high demand on oxidative metabolism
are known to be vulnerable to an impairment of mitochon-
drial functions. Moreover, MrpL32 processing and mito-
chondrial translation were less severely affected in par-
aplegin-deficient murine mitochondria than in yeast,
indicating that another peptidase (or peptidases) can
substitute for loss of the paraplegin-containing m-AAA
protease. It is therefore also conceivable that the tissue
specificity is caused by differences in the expression
patterns of MrpL32 processing peptidases. Clearly, fur-
ther studies are required to unravel the molecular basis
for HSP pathogenesis. The functional link of the m-AAA
protease to ribosome assembly and protein synthesis
within mitochondria may lead the way.
Experimental Procedures
Cloning Procedures
For SP6-polymerase-driven expression in vitro, yeast MRPL32 and
fragments thereof were amplified by PCR and cloned into either
the vector pCRII-TOPO, pGEM4, or pGEM4-DHFR, respectively.
Similarly, murine MRPL32 was amplified by PCR from murine cDNA
and cloned into pGEM4.
To allow expression of Yta10E559Q harboring a C-terminal hexa-
histidine peptide in yeast, a DNA fragment of YTA10E559Q (bp 1010–
2316) was PCR amplified and cloned into YCplac22ADH1-Yta10E559Q
(Arlt et al., 1998). For expression of the hybrid protein Su9 (1–69)-
MrpL32 (72–183), the respective MRPL32 DNA fragment was ampli-
fied by PCR and cloned into the vector pVT100U-mtGFP. For com-
plementation studies in yeast, mature forms of murine paraplegin
(amino acids 44–781) and Afg3l2 (amino acids 36–802) were fused
to the mitochondrial targeting sequence of Yta10 (amino acids
1–61). A HA epitope was attached to the C terminus of Afg3l2 to
facilitate immunodetection. The hybrid proteins were cloned into
the plasmids YEplac181 or YEplac112, respectively, and expressed
under the control of the YTA10 promoter (480 bp).Yeast Strains and Growth Conditions
All S. cerevisiae strains used in this study are derivatives of W303.
The strain yta10EQ/HISyta12EQ (YMN101) was generated by trans-
formation of plasmids YCplac22ADH1-Yta10E559QHis and YCpla-
c111ADH1-Yta12E614Q into yta10yta12 (YHA301) cells (Arlt et al.,
1998). The strains yta10yta12, yta10EQyta12EQ expressing
Yta10E559Q and Yta12E614Q (YGS302), yta10 (YGS101), yta10EQ
(yta10E559Q, YHA103), yta12EQ (yta12E614Q, YHA203) (Arlt et al.,
1998), and yme1 (Leonhard et al., 1996) were described pre-
viously. The strains mrpl32 (YMN201) or yta12 (YSW1) were ob-
tained by deletion of MRPL32 or YTA12 in W303-1A by PCR-tar-
geted homologous recombination. The plasmids pVT100U-Su9
(1–69)-MrpL32 (72–183) and YCplac111MRPL32-MrpL32 were trans-
formed into a diploid MRPL32/mrpl32 strain (YMN301). Haploid
spores harboring the mrpl32 deletion and the plasmid pVT100U-
Su9 (1–69)-MrpL32 (72–183) (YMN312) or YCplac111MRPL32-MrpL32
(YMN311) were isolated by sporulation and tetrad dissection. The
strain yta10 expressing Su9 (1–69)-MrpL32 (72–183) (YMN102)
was generated by transformation of pVT100U-Su9 (1–69)-MrpL32
(72–183) into yta10 (YGS101). yta10mrpl32 cells expressing
Su9 (1–69)-MrpL32 (72–183) (YMN313) were obtained by deletion
of YTA10 in the strain YMN312. The strain yta10yta12 expressing
murine Afg3l2 and paraplegin (YKO267) was generated by trans-
formation of plasmids YEplac181YTA10-Yta10 (1–61)-paraplegin (44–
781) and YEplac112YTA10-Yta10 (1–61)-Afg3l2 (36–802)-HA into
yta10yta12 (YHA301) cells.
Metal Chelating Chromatography
Mitochondria (20 mg) were isolated from yta10EQ/HISyta12 or
yta10EQyta12EQ cells and solubilized at 4 mg/ml in buffer A (2%
[w/v] digitonin, 1 mM ATP, 1 mM PMSF, EDTA-free protease inhibi-
tor cocktail [Roche] in 1× PBS [140 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1,8 mM KH2PO4]) by incubation for 30 min at 4°C under
gentle mixing (1400 rpm). Insoluble material was removed by cen-
trifugation for 30 min at 125,000 × g at 4°C. The supernatant was
loaded onto a Ni2+-conjugated Hi-trap chelating column (1 ml).
Bound proteins were eluted by extensive washing (10 column vol-
umes) with 100 mM and 400 mM imidazole in buffer B (0.5% [w/v]
digitonin, 1 mM ATP in 1× PBS). Proteins eluted at a concentration
of 400 mM imidazole were TCA precipitated and analyzed by SDS-
PAGE and colloidal Coomassie stain.
Sucrose-Gradient Centrifugation of Ribosomal Particles
Mitochondria (300 g) were solubilized with 400 l buffer C (1%
[w/v] digitonin, 20 mM HEPES-KOH [pH 7.4], 80 mM KCl, 10 mM
MgSO4, 20 mM MgCl2, 0.5 mM PMSF] for 30 min at 4°C under
gentle shaking (1400 rpm). After a clarifying spin for 15 min at
21,000 × g and 4°C, the supernatant was loaded on top of a linear
sucrose gradient (23%–40%, 4 ml) in 0.1% (w/v) digitonin, 20 mM
HEPES-KOH (pH 7.4), 50 mM MgSO4, 20 mM MgCl2, 0.5 mM PMSF
and centrifuged for 3 hr at 270,000 × g and 4°C. Fractions of 400
l were collected, precipitated with TCA, and analyzed by SDS-
PAGE and immunoblotting. Ribosomal particles were detected by
absorption measurements at 254 nm using a continuous flow cell
of a Thermo UV1 photometer.
Antibody Production
The peptides C-RWLREKLQQDHKDTE and C-HTAKEEIKPRQEEEL,
corresponding to amino acid residues 45–59 and 131–145 of yeast
MrpL32, respectively, were used for generation of polyclonal anti-
bodies in rabbits. A polyclonal antiserum directed against murine
MrpL32 was generated using the peptide C-RRTIEVNRSRRRN
PQK, corresponding to amino acids 83–98 of murine MrpL32.
Southern Blot Analysis of mtDNA
Genomic DNA was isolated from liver using standard techniques.
Ten micrograms of total DNA was digested with BglII to linearize
the mtDNA, subjected to electrophoresis on a 0.9% (w/v) agarose
gel, and transferred to a Hybond N+ membrane. The blot was hy-
bridized using the ECL Direct Nucleic Acid Labeling and Detection
System (Amersham) with probes corresponding to ND-1 (nucleo-




The following procedures were performed essentially as described:
isolation of yeast and murine liver mitochondria and labeling of
mitochondrial-translation products in yeast cells and isolated mu-
rine liver mitochondria (Tatsuta and Langer, 2005), protein import
into isolated yeast mitochondria and swelling of mitochondria
(Kambacheld et al., 2005), TX-114 extraction (Knittler et al., 1998),
sonication of mitochondria (Liu and Spremulli, 2000), and gel filtra-
tion analysis (Arlt et al., 1996).
Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.cell.com/cgi/content/full/123/2/277/
DC1/.
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